CD47 ligation selectively downregulates human interleukin 12 production

Area of Science:

• Immunology
• Cell Biology
• Molecular Medicine

Background:

• Interleukin (IL)-12 is crucial for T helper cell type 1 (Th1) responses and chronic inflammatory diseases.
• Monocytes are key immune cells involved in inflammatory processes.
• CD47 is a cell surface receptor with diverse functions in immune regulation.

Purpose of the Study:

• To investigate the role of CD47 engagement in regulating IL-12 production by monocytes.
• To explore the potential of CD47 as a therapeutic target for Th1-mediated inflammatory conditions.

Main Methods:

• Monocytes were stimulated and treated with anti-CD47 monoclonal antibody, thrombospondin (TSP), or TSP-derived peptide (4N1K).
• IL-12 production was measured using ELISA.
• The involvement of phosphoinositide 3-kinase (PI3K) pathway was assessed using specific inhibitors.

Main Results:

• Engagement of CD47 selectively inhibited IL-12 release from monocytes without affecting other cytokines like TNF-alpha, IL-1, IL-6, or GM-CSF.
• This suppression was independent of Fcgamma receptor ligation and extracellular Ca(2+) influx.
• The inhibitory effect on IL-12 was reversed by PI3K inhibitors, indicating PI3K pathway involvement.

Conclusions:

• CD47 ligation by TSP represents a novel mechanism for selective downregulation of IL-12 production in monocytes.
• This pathway could be therapeutically exploited to limit inflammation in Th1-mediated diseases.
• Targeting CD47 offers a potential strategy for managing chronic inflammatory conditions.